Previous Article | Next Article 
Journal of Clinical Microbiology, July 2003, p. 3392-3394, Vol. 41, No. 7
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.7.3392-3394.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Analysis of Genetic Identity of North American Anaplasma phagocytophilum Strains by Pulsed-Field Gel Electrophoresis
J. S. Dumler,1* K. M. Asanovich,1,
and J. S. Bakken2
Division of Medical Microbiology, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205,1
Infectious Diseases, SMDC Health System, Duluth, Minnesota 558052
Received 3 March 2003/
Returned for modification 25 March 2003/
Accepted 27 March 2003

ABSTRACT
Biological and geographic heterogeneity of anthropozoonosis
caused by
Anaplasma phagocytophilum is poorly understood. Seven
North American
A. phagocytophilum strains were compared by PFGE.
The average genome size was 1.58 Mbp, and restriction patterns
were identical. New World strains of
A. phagocytophilum have
a large genome and a high degree of genetic uniformity.

TEXT
The recently renamed
Anaplasma (
Ehrlichia)
phagocytophilum is
an obligate intracellular bacterium that causes disease in humans,
horses, dogs, and ruminants (
5,
7). These organisms were originally
classified as distinct species because of apparent diverse hosts
and relatively remote geographic distributions. However, genetic
and antigenic analyses showed only minor differences among
Ehrlichia phagocytophila,
Ehrlichia equi, and the human granulocytic ehrlichiosis
(HGE) agent and revealed a close relationship to
Anaplasma marginale,
a ruminant erythrocyte pathogen (
7). The new taxonomic assignment
creates a single species but allows for biological and clinical
heterogeneity, as is evident with the disparity between seroprevalence
and incidence in humans and horses in North America and ruminants
in Europe, in clinical severity between geographic locations
in North America and Europe, and between clinical manifestations
of infection in various mammalian hosts (
1,
2,
4,
8-
10,
11,
14,
19). The clinical and host tropism diversity suggest undiscovered
differences among these bacteria. Thus, to determine whether
A. phagocytophilum genomic variation might explain some heterogeneity,
we analyzed genomic DNA of North American human, equid, and
canid isolates by pulsed-field gel electrophoresis (PFGE).
(This work was presented in part at the Annual Meeting of the American Society for Tropical Medicine and Hygiene, Washington, D.C., November 1999.)
A. phagocytophilum (HGE agent and E. equi) strains (Table 1) were cultivated from peripheral blood in HL-60 cells and were passaged from 2 to 20 times prior to DNA preparation (3). The isolates were verified by PCR amplification and/or 16S rRNA gene sequencing and by reaction with A. phagocytophilum Msp2 (p44) monoclonal antibody. To preclude host cell DNA contamination, bacteria were purified from heavily infected HL-60 cells as previously described (3). Briefly, infected cells were harvested by centrifugation (500 x g at 4°C), resuspended in sucrose phosphate glutamine buffer (SPGn), and lysed by sonication on ice. Host cell debris was removed by centrifugation (500 x g), and the bacteria-enriched supernatant was treated with DNase I and RNase A (50 µg/ml) for 45 min at 37°C. Bacteria were centrifuged on discontinuous 45 and 30% meglumine diatrizoate density gradients for 1 h at 26,000 x g. The gradient interface was harvested and washed with SPGn. Protein concentration was determined, and suspensions were frozen at -80°C until they were used.
Thawed bacteria were embedded in 0.8% InCert agarose (FMC) in
Bio-Rad PFGE plug molds by using sufficient bacteria to obtain
2.5 mg of protein/ml in a solution containing 10 mM Tris, 150
mM NaCl, 2 mM EDTA (pH 8.0). Genomic DNA was prepared by digestion
in buffer containing 100 mM EDTA, 10 mM Tris, 1% sodium dodecyl
sulfate (pH 8.0) with 1 mg of proteinase K/ml for two 24-h cycles
at 37°C. The proteinase K was inactivated by three 1-h washes
in a solution of 10 mM Tris (pH 8.0), 2 mM EDTA with 1 mM phenylmethylsulfonyl
fluoride at room temperature and then three washes in 10 mM
Tris (pH 8.0), and the plugs were finally stored in 200 mM EDTA.
Genomic DNA in agarose plugs was equilibrated in restriction
enzyme buffer for 1 h and was digested in 300 µl of 1
x restriction enzyme with bovine serum albumin carrier, if required,
overnight at an appropriate temperature. Each plug was equilibrated
with 0.5
x Tris-borate-EDTA (TBE) for 30 min and was applied
to the gel. Various restriction enzymes were assessed for resolution
and for a small number of bands, including
AscI,
EagI,
PmeI,
SwaI,
SgfI,
SmaI,
BssHII,
BclI,
Eco47III,
EcoRI,
EcoRV,
HindIII,
HpaI,
NsiI,
SspI,
XbaI,
PmaCI,
AgeI,
PstI,
ApaI,
KpnI,
NotI,
NheI,
SpeI,
XhoI,
SnaBI,
PacI,
RsrII,
DraI,
PvuI, and
SfuI.
The restriction enzyme-digested DNAs were separated by electrophoresis
by using a Bio-Rad contour-clamped homogeneous electric field
system and 1.6% Seakem Gold agarose (FMC) with the following
empirically determined parameters: pulse times, initial 15 s
and final 70 s; voltage, 6 V/cm; run time, 26 h; buffer, 0.5
x TBE. Agarose gels were stained with ethidium bromide and were
visualized. Molecular sizes of bands were recorded and compared
by using the Bio-Rad Molecular Analyst and Fingerprinting Software,
version 1.4.1.
The restriction enzymes AscI, EagI, PmeI, SwaI, and SgfI reproducibly produced 3 to 11 bands. Each A. phagocytophilum isolate had identical PFGE patterns for any one enzyme (Fig. 1). Based on the sum of the molecular sizes of all bands, the average size of the A. phagocytophilum group genome was 1.58 Mbp, as previously documented for the Webster strain, and was much larger than the genome sizes of any other Anaplasmataceae or Rickettsiale (15).
A high degree of diversity in clinical disease exists among
strains of
A. phagocytophilum that cause infections and disease
worldwide (
5,
9). The initial classification into European ruminant
(
E. phagocytophila), North American equine and canine (
E. equi),
and human or canine (HGE agent) strains belies such diversity.
Although unification of these species into a single
Anaplasma species is largely accepted, differences in infectivity and
clinical disease are acknowledged (
1,
4,
7,
9,
10,
13,
14,
17).
Although the PFGE data presented here provide further support
for the new taxonomic classification, no genetic attributes
explain the biological and clinical differences.
HGE is more often described as a more severe infection in North America than in Europe (5, 9). Similarly, ruminant disease that is frequent in Europe is rare in North America (14, 16). Analyses of A. phagocytophilum genes show that North American strains differ more from European strains than they do from each other (6, 12, 18). In fact, analysis of groESL and ankA seem to confirm greater diversity among European strains, implying a longer interval of evolution that may correlate with the greater diversity of manifestations in European animals.
Complete genome sequences for many of the Anaplasmataceae will shortly become available, but considerable time may pass before genomic comparisons are able to provide information about diversity among organisms of a single species. The data here confirm determinations of the size of the A. phagocytophilum genome as well as the high degree of similarity among North American strains. Although PFGE interrogates only limited regions of the genome, it is interesting that differences in neither genome size nor restriction enzyme digestion pattern could be discerned, even among isolates from opposite sides of the continent. However, analysis by using other tools better designed to demonstrate differences, such as multilocus sequence typing, might improve detection of variations to correlate with biological behavior.
PFGE predicts that North American A. phagocytophilum has little heterogeneity, and potentially the reservoirs, infectious potential, and pathogenicity of this bacterium may be similar throughout North America (12, 18). A precise determination awaits further investigation of reservoirs and infections in humans and mammals with clinical signs.

ACKNOWLEDGMENTS
This work was supported in part by grant RO1 AI-41213-01 from
the National Institutes of Allergy and Infectious Diseases.
Special thanks are given to Susan Harrington for help with PFGE and to John E. Madigan, Maria Aguero-Rosenfeld, and Gary Wormser for help in obtaining isolates.

FOOTNOTES
* Corresponding author. Mailing address: Division of Medical Microbiology, Department of Pathology, The Johns Hopkins University School of Medicine, Ross Building, Rm. 624, 720 Rutland Ave., Baltimore, MD 21205. Phone: (410) 955-8654. Fax: (443) 287-3665. E-mail:
sdumler{at}jhmi.edu.

Present address: College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061.

Present address: College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061. 

REFERENCES
1 - Aguero-Rosenfeld, M. E., L. Donnarumma, L. Zentmaier, J. Jacob, M. Frey, R. Noto, C. A. Carbonaro, and G. P. Wormser. 2002. Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J. Clin. Microbiol. 40:2612-2615.[Abstract/Free Full Text]
2 - Alberdi, M. P., A. R. Walker, and K. A. Urquhart. 2000. Field evidence that roe deer (Capreolus capreolus) are a natural host for Ehrlichia phagocytophila. Epidemiol. Infect. 124:315-323.[CrossRef][Medline]
3 - Asanovich, K. M., J. S. Bakken, J. E. Madigan, M. Aguero-Rosenfeld, G. P. Wormser, and J. S. Dumler. 1997. Antigenic diversity of granulocytic Ehrlichia isolates from humans in Wisconsin and New York and a horse in California. J. Infect. Dis. 176:1029-1034.[Medline]
4 - Bakken, J. S., P. Goellner, M. Van Etten, D. Z. Boyle, O. L. Swonger, S. Mattson, J. Krueth, R. L. Tilden, K. Asanovich, J. Walls, and J. S. Dumler. 1998. Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin. Clin. Infect. Dis. 27:1491-1496.[Medline]
5 - Bakken, J. S., and J. S. Dumler. 2000. Human granulocytic ehrlichiosis. Clin. Infect. Dis. 31:554-560.[CrossRef][Medline]
6 - Caturegli, P., K. M. Asanovich, J. J. Walls, J. S. Bakken, J. E. Madigan, V. L. Popov, and J. S. Dumler. 2000. ankA: an Ehrlichia phagocytophila group gene encoding a cytoplasmic protein antigen with ankyrin repeats. Infect. Immun. 68:5277-5283.[Abstract/Free Full Text]
7 - Dumler, J. S., A. F. Barbet, C. P. Bekker, G. A. Dasch, G. H. Palmer, S. C. Ray, Y. Rikihisa, and F. R. Rurangirwa. 2001. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. Int. J. Syst. Evol. Microbiol. 51:2145-2165.[Abstract]
8 - Foley, J. E., J. E. Barlough, R. B. Kimsey, J. E. Madigan, E. DeRock, and A. Poland. 1998. Ehrlichia spp. in cervids from California. J. Wildl. Dis. 34:731-737.[Abstract]
9 - Lotric-Furlan, S., T. Avsic-Zupanc, M. Petrovec, W. L. Nicholson, J. W. Sumner, J. E. Childs, and F. Strle. 2001. Clinical and serological follow-up of patients with human granulocytic ehrlichiosis in Slovenia. Clin. Diagn. Lab. Immunol. 8:899-903.[Abstract/Free Full Text]
10 - Madigan, J. E., S. Hietala, S. Chalmers, and E. DeRock. 1990. Seroepidemiologic survey of antibodies to Ehrlichia equi in horses of northern California. J. Am. Vet. Med. Assoc. 196:1962-1964.[Medline]
11 - Magnarelli, L. A., J. W. Ijdo, K. C. Stafford III, and E. Fikrig. 1999. Infections of granulocytic ehrlichiae and Borrelia burgdorferi in white-tailed deer in Connecticut. J. Wildl. Dis. 35:266-274.[Abstract]
12 - Massung, R. F., J. H. Owens, D. Ross, K. D. Reed, M. Petrovec, A. Bjoersdorff, R. T. Coughlin, G. A. Beltz, and C. I. Murphy. 2000. Sequence analysis of the ank gene of granulocytic ehrlichiae. J. Clin. Microbiol. 38:2917-2922.[Abstract/Free Full Text]
13 - Petrovec, M., A. Bidovec, J. W. Sumner, W. L. Nicholson, J. E. Childs, and T. Avsic-Zupanc. 2002. Infection with Anaplasma phagocytophila in cervids from Slovenia: evidence of two genotypic lineages. Wien. Klein. Wochenschr. 114:641-647.
14 - Pusterla, N., J. B. Pusterla, U. Braun, and H. Lutz. 1999. Experimental cross-infections with Ehrlichia phagocytophila and human granulocytic ehrlichia-like agent in cows and horses. Vet. Rec. Sep. 145:311-314.[Abstract/Free Full Text]
15 - Rydkina, E., V. Roux, and D. Raoult. 1999. Determination of the genome size of Ehrlichia spp., using pulsed field gel electrophoresis. FEMS Microbiol. Lett. 176:73-78.[CrossRef][Medline]
16 - Stuen, S., and K. Bergstrom. 2001. Serological investigation of granulocytic Ehrlichia infection in sheep in Norway. Acta Vet. Scand. 42:331-338.[Medline]
17 - Stuen, S., I. Van De Pol, K. Bergstrom, and L. M. Schouls. 2002. Identification of Anaplasma phagocytophila (formerly Ehrlichia phagocytophila) variants in blood from sheep in Norway. J. Clin. Microbiol. 40:3192-3197.[Abstract/Free Full Text]
18 - Sumner, J. W., W. L. Nicholson, and R. F. Massung. 1997. PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species. J. Clin. Microbiol. 35:2087-2092.[Abstract]
19 - Walls, J. J., K. M. Asanovich, J. S. Bakken, and J. S. Dumler. 1998. Serologic evidence of a natural infection of white-tailed deer with the agent of human granulocytic ehrlichiosis in Wisconsin and Maryland. Clin. Diagn. Lab. Immunol. 5:762-765.[Abstract/Free Full Text]
Journal of Clinical Microbiology, July 2003, p. 3392-3394, Vol. 41, No. 7
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.7.3392-3394.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Granquist, E. G., Stuen, S., Lundgren, A. M., Braten, M., Barbet, A. F.
(2008). Outer Membrane Protein Sequence Variation in Lambs Experimentally Infected with Anaplasma phagocytophilum. Infect. Immun.
76: 120-126
[Abstract]
[Full Text]
-
Bown, K. J., Lambin, X., Ogden, N. H., Petrovec, M., Shaw, S. E., Woldehiwet, Z., Birtles, R. J.
(2007). High-Resolution Genetic Fingerprinting of European Strains of Anaplasma phagocytophilum by Use of Multilocus Variable-Number Tandem-Repeat Analysis. J. Clin. Microbiol.
45: 1771-1776
[Abstract]
[Full Text]
-
de la Fuente, J., Massung, R. F., Wong, S. J., Chu, F. K., Lutz, H., Meli, M., von Loewenich, F. D., Grzeszczuk, A., Torina, A., Caracappa, S., Mangold, A. J., Naranjo, V., Stuen, S., Kocan, K. M.
(2005). Sequence Analysis of the msp4 Gene of Anaplasma phagocytophilum Strains. J. Clin. Microbiol.
43: 1309-1317
[Abstract]
[Full Text]
-
Poitout, F. M., Shinozaki, J. K., Stockwell, P. J., Holland, C. J., Shukla, S. K.
(2005). Genetic Variants of Anaplasma phagocytophilum Infecting Dogs in Western Washington State. J. Clin. Microbiol.
43: 796-801
[Abstract]
[Full Text]
-
Lin, Q., Rikihisa, Y., Massung, R. F., Woldehiwet, Z., Falco, R. C.
(2004). Polymorphism and Transcription at the p44-1/p44-18 Genomic Locus in Anaplasma phagocytophilum Strains from Diverse Geographic Regions. Infect. Immun.
72: 5574-5581
[Abstract]
[Full Text]
-
Levin, M. L., Coble, D. J., Ross, D. E.
(2004). Reinfection with Anaplasma phagocytophilum in BALB/c Mice and Cross-Protection between Two Sympatric Isolates. Infect. Immun.
72: 4723-4730
[Abstract]
[Full Text]
-
Lin, Q., Rikihisa, Y., Felek, S., Wang, X., Massung, R. F., Woldehiwet, Z.
(2004). Anaplasma phagocytophilum Has a Functional msp2 Gene That Is Distinct from p44. Infect. Immun.
72: 3883-3889
[Abstract]
[Full Text]